MétaCan
Menu
← Back to cohort
Record W4416141004 · doi:10.1093/neuonc/noaf201.0150

BIOM-62. BASELINE NEUROLOGICAL FUNCTION ASSESSED BY NANO PREDICTS PROGRESSION-FREE SURVIVAL IN GLIOBLASTOMA

2025· article· en· W4416141004 on OpenAlexaffabout
Javeria Raheem, Aimee Chan, Marie Allen, Rachel Fox, Aimee Theriault, Inga Granovskaya, Andrea S.L. Wong, Eirena Calabrese, Katrina Roberto, Jaime Godoy-Santín, John Y. Rhee, Patrick Y. Wen, David A. Reardon, James Perry, Lakshmi Nayak, Mary Jane Lim-Fat

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsHealth Sciences CentreUniversity of TorontoSunnybrook HospitalSunnybrook Health Science Centre
Fundersnot available
KeywordsGlioblastomaCohortOverall survivalProportional hazards modelGliomaProgression-free survivalSurvival analysisKarnofsky Performance Status

Abstract

fetched live from OpenAlex

Abstract BACKGROUND The Neurologic Assessment in Neuro-Oncology (NANO) scale is a standardized clinician-friendly tool consisting of nine domains to assess neurological status in brain tumor patients. Combined with MRI, NANO offers a comprehensive clinician response outcome, particularly when clinical and radiologic responses diverge. Despite its growing use in clinical trials, NANO’s association with progression-free survival (PFS) and overall survival (OS) in glioblastoma (GBM) remains underexplored. METHODS The Molecular, Imaging, and Neurological Assessment Database for CNS tumors (MIND-CNS) is a prospective, multimodal database capturing molecular, imaging, and neurological information—including NANO scores and Karnofsky Performance Status (KPS) —at baseline and follow-up visits in glioma patients. We analyzed baseline NANO scores in relation to PFS in a real-world cohort of GBM patients. Survival distributions were compared using log-rank tests, and covariate effects were estimated via Cox proportional hazards models. RESULTS We evaluated 85 GBM patients (59% male, median age 63) with baseline NANO scores as part of their assessment at a tertiary Canadian center. Patients with any neurological deficit at baseline showed a trend towards shorter PFS (p < 0.06). Specifically, deficits in gait (p < 0.001), strength (p < 0.001), and facial function (p < 0.03) were associated with shorter PFS. Greater neurological deficit in multiple domains (higher cumulative baseline NANO score) also predicted shorter PFS (p < 0.04) and higher rates of progression at 3 months (p < 0.04), independent of age, sex, and MGMT promoter methylation status. KPS score was also independently associated with PFS at 3 months (p <0.04). CONCLUSION Baseline NANO scores predict PFS and early progression in GBM patients. While KPS also correlated with outcomes, NANO offered greater granularity by identifying specific deficits. A combined international cohort analysis of GBM patients (n = 181) is underway to further evaluate associations with overall survival.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.034
Threshold uncertainty score0.068

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.305
Teacher spread0.290 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueNeuro-Oncology→Same topicGlioma Diagnosis and Treatment→French-language works237,207→